Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
Ovarian Cycle01:27

Ovarian Cycle

The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle length...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Increasing Uptake of COVID-19 Vaccination and Reducing Health Inequalities in Patients on Renal Replacement Therapy-Experience from a Single Tertiary Centre.

Vaccines·2022
Same author

Predictive Analysis of Gallbladder Wall Thickness as a Marker for Bleeding Risk and Need for Transfusion in Dengue Patients.

Japanese journal of infectious diseases·2021
Same author

Assessing the Mental Impact and Burnout among Physicians during the COVID-19 Pandemic: A Developing Country Single-Center Experience.

The American journal of tropical medicine and hygiene·2021
Same author

Impact of Fasting Lipid Profile on Chronic Kidney Disease Patients Having Fatty Liver Disease.

Cureus·2020
Same author

Pericardial Tumor, a Rare Manifestation of Sjogren's Syndrome Secondary to Systemic Lupus Erythematosus.

Cureus·2020
Same author

Massive Ovarian Edema Mimicking Malignancy.

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP·2020

Related Experiment Video

Updated: Jun 27, 2026

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
07:43

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas

Published on: January 17, 2018

Pregnancy with macroprolactinoma.

Shazia Abid1, Iftikhar Sadiq, Saira Anwar

  • 1Department of Obstetrics and Gynaecology, Sharif Medical and Dental Hospital, Lahore. dr_shaziaabid@hotmail.com

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
|November 27, 2008
PubMed
Summary

A recurrent macroprolactinoma caused vision loss during pregnancy. Surgical removal improved vision, but medication adjustments were needed to manage elevated prolactin levels.

More Related Videos

X-Ray Visualization of Intraductal Ethanol-Based Ablative Treatment for Prevention of Breast Cancer in Rat Models
12:57

X-Ray Visualization of Intraductal Ethanol-Based Ablative Treatment for Prevention of Breast Cancer in Rat Models

Published on: December 9, 2022

Related Experiment Videos

Last Updated: Jun 27, 2026

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
07:43

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas

Published on: January 17, 2018

X-Ray Visualization of Intraductal Ethanol-Based Ablative Treatment for Prevention of Breast Cancer in Rat Models
12:57

X-Ray Visualization of Intraductal Ethanol-Based Ablative Treatment for Prevention of Breast Cancer in Rat Models

Published on: December 9, 2022

Area of Science:

  • Endocrinology
  • Neuro-oncology
  • Reproductive Medicine

Background:

  • Macroprolactinomas, a type of pituitary tumor, can cause infertility, amenorrhea, and galactorrhea.
  • Tumor growth during pregnancy can lead to significant complications, including visual impairment due to optic chiasm compression.

Purpose of the Study:

  • To report a case of recurrent macroprolactinoma presenting with visual loss during pregnancy.
  • To discuss the management challenges and treatment outcomes in such cases.

Main Methods:

  • Case presentation of a 25-year-old female with recurrent macroprolactinoma.
  • Diagnostic workup including MRI and serum prolactin levels.
  • Treatment modalities included bromocriptine, transsphenoidal adenectomy, and lisuride hydrogen.

Main Results:

  • Initial bromocriptine treatment normalized prolactin and restored fertility.
  • Tumor enlargement during pregnancy caused severe headache and vision loss.
  • Transsphenoidal adenectomy improved visual fields, but prolactin remained elevated.
  • Post-surgery, bromocriptine (15 mg/day) was ineffective, but lisuride hydrogen (0.8 mg/day) successfully reduced prolactin levels.

Conclusions:

  • Recurrent macroprolactinoma poses significant risks during pregnancy, necessitating careful monitoring.
  • Multimodal treatment including surgery and pharmacotherapy is crucial for managing these complex cases.
  • Lisuride hydrogen demonstrated efficacy in controlling hyperprolactinemia when bromocriptine failed.